Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy Toxicity”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Not applicableUnknownNCT04721184
What this trial is testing

Impact of Low Muscle Mass in HNC Treated With Immunotherapy

Who this might be right for
Head and Neck Small Cell CarcinomaSarcopenia
Institut Català d'Oncologia 120
Not applicableUnknownNCT04807127
What this trial is testing

A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint Blockade

Who this might be right for
Pneumonitis, InterstitialImmunotherapyImmune-related Adverse Events
Universitaire Ziekenhuizen KU Leuven 60
Not applicableUnknownNCT04579978
What this trial is testing

Tumor Immunotherapy and Microbiome Analysis

Who this might be right for
Advanced Solid Tumor
Sunnybrook Health Sciences Centre 60
Not applicableLooking for participantsNCT04615988
What this trial is testing

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

Who this might be right for
ThyroidPD-1Cancer
Icahn School of Medicine at Mount Sinai 17
Not applicableStudy completedNCT03447483
What this trial is testing

Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE).

Who this might be right for
Solid Tumor
Institut Claudius Regaud 150
Not applicableLooking for participantsNCT06461780
What this trial is testing

Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy

Who this might be right for
CancerImmunotherapyIrAE+4 more
Taipei Veterans General Hospital, Taiwan 200
Testing effectiveness (Phase 2)Study completedNCT00109005
What this trial is testing

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Looking for participantsNCT06589089
What this trial is testing

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 18
Testing effectiveness (Phase 2)UnknownNCT04631731
What this trial is testing

Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity

Who this might be right for
Lung Cancer, Nonsmall CellRenal Cell CarcinomaMelanoma+4 more
Western Sydney Local Health District 200
Not applicableLooking for participantsNCT07138222
What this trial is testing

IMmune checkPoint Inhibitor Related gonAdal toxiCiTy in Premenopausal Women and Men With Melanoma

Who this might be right for
Melanoma (Skin Cancer)
Peter MacCallum Cancer Centre, Australia 80
Not applicableLooking for participantsNCT07382752
What this trial is testing

Decoupling Immunotherapy Toxicity and Cancer Response

Who this might be right for
TumorCardiovascular
M.D. Anderson Cancer Center 1,200
Early research (Phase 1)WithdrawnNCT01336478
What this trial is testing

CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation

Who this might be right for
Haematological MalignanciesAllogeneic Stem Cell TransplantCD56+CD3- NK Cells
Imperial College London
Not applicableActive Not RecruitingNCT03827343
What this trial is testing

Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer

Who this might be right for
Macrophage Activation SyndromePrimary Hemophagocytic Lymphohistiocytosis
National Cancer Institute (NCI) 500
Not applicableLooking for participantsNCT06688422
What this trial is testing

Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy

Who this might be right for
Lung CancerPneumonitisRadiation-Induced Lung Injury+2 more
The Cooper Health System 100
Early research (Phase 1)Not Yet RecruitingNCT06217666
What this trial is testing

Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)

Who this might be right for
Pancreatic Adenocarcinoma
Haoming (Carl) Qiu 24
Not applicableActive Not RecruitingNCT04711330
What this trial is testing

Response and Toxicity Prediction by Microbiome Analysis After (Concurrent) Chemoradiotherapy

Who this might be right for
Non Small Cell Lung Cancer Stage IIIImmunotherapy
Leiden University Medical Center 126
Testing effectiveness (Phase 2)UnknownNCT03638375
What this trial is testing

TIL and Anti-PD1 in Metastatic Melanoma

Who this might be right for
Toxicity, DrugAdverse Drug EventEffects of Immunotherapy
Leiden University 34
Early research (Phase 1)Study completedNCT01435499
What this trial is testing

Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Early research (Phase 1)Looking for participantsNCT07169487
What this trial is testing

Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study

Who this might be right for
Cytokine Release SyndromeICANS
Institute of Hematology & Blood Diseases Hospital, China 18
Not applicableLooking for participantsNCT03514368
What this trial is testing

Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy

Who this might be right for
Solid Cancers
Institut Claudius Regaud 770
Next Page